Skip to main content
Human Health News
AEMPS authorizes phase III clinical trial of the HIPRA’s vaccine against Covid-19
25-03-2022
Human
Explore
The European RBDCOV project will study HIPRA’s Covid-19 vaccine in children, adolescents and immunocompromised patients
24-03-2022
Human
Explore
HIPRA plans to produce 400 million doses of its SARS-CoV-2 HIPRA vaccine during 2022
16-04-2021
Human
Explore
HIPRA takes a firm step towards human health with research and manufacture of a Covid-19 vaccine
11-12-2020
Human
Explore
HIPRA makes its biotechnology facilities and equipment available to the health authorities
26-03-2020
Human
Explore
HIPRA at your side to guarantee service (COVID-19)
19-03-2020
Human
Explore